Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT02910258
Eligibility Criteria:
Inclusion Criteria:
* Primary or secondary Myelofibrosis
* Prescription of pegylated interferon α2a
* Age \> 18 years-old
Exclusion Criteria:
* Other MPNs treated with pegylated interferon α2a
* Patients treated for PMF or SMF but without pegylated interferon
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02910258
Study Brief:
Protocol Section:
NCT02910258